Renal safety of tenofovir in HIV-infected children: A prospective, 96-week longitudinal study

Clinical Drug Investigation

Volumn 27, Issue 8, 2007, Pages 573-581

  Vigano A ^a   Zuccotti, G V ^a   Martelli, L ^a   Giacomet, V ^a   Cafarelli, L ^a   Borgonovo, S ^a   Beretta, S ^a   Rombola G ^b   Mora, S ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; TENOFOVIR;

ADOLESCENT; ARTICLE; BICARBONATE BLOOD LEVEL; BODY COMPOSITION; CD4 LYMPHOCYTE COUNT; CHILD; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG SAFETY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSURIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPHOSPHATEMIA; KIDNEY TUBULE FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NEPHROTOXICITY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SIDE EFFECT; STATISTICAL ANALYSIS; VIRUS LOAD;

ADENINE; ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MALE; PHOSPHONIC ACIDS; PROSPECTIVE STUDIES;

EID: 34547189266     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200727080-00006     Document Type: Article

References (37)

1. Hazra R, Gafni RI, Maldarelli F, et al. Tenofovir disoproxil fumarate and optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection. Pediatrics 2005 Dec; 116 (6): e846-54
2. Viganò A, Aldrovandi GM, Giacomet V, et al. Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children. Antiv Ther 2005; 10 (8): 917-24
3. Viganò A, Giacomet V, Martelli L, et al. Lipodystrophy and other metabolic complications in pediatric populations [abstract no. 692]. 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5-8; Denver (CO)
4. Ho ES, Lin DC, Mendel DB, et al. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 2000 Mar; 11 (3): 383-93
5. Nelson M, Cooper D, Schooley R, et al. The safety of tenofovir DF for the treatment of HIV infection: the first 4 years [abstract no. 781]. 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5-8; Denver (CO)
6. Izzedine H, Isnard-Bagnis C, Hulot JS, et al. Renal safety of tenofovir in HIV treatment experienced patients. AIDS 2004 Apr; 18 (7): 1074-6
7. Schooley RT, Ruane P, Myers RA, et al. Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study. AIDS 2002 Jun; 16 (9): 1257-63
8. Squires K, Pozniak AL, Pierone Jr G, et al. Study 907 team. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial. Ann Intern Med 2003 Sep; 139 (5PT1): 313-20
9. Guest J, Rimland D, Patterson B, et al. Tenofovir-induced nephrotoxicity in the first year of therapy [abstract no. 778]. 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5-8; Denver (CO)
10. Crane H, Harrington R, Van Rompaey, et al. Didanosine and lower baseline body weight are associated with declining renal function among patients receiving tenofovir [abstract no. 780]. 13th Conference on Retroviruses and Opportunistic Infections; 2006 Feb 5-8; Denver (CO)
11. Lin J, Knight EL, Hogan ML, et al. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003 Oct; 14 (10): 2573-80
12. Rule AD, Larson TS, Bergstralh EJ, et al. Using serum creatiinine to estimate glomerular filtration rate: accuracy in good health and chronic kidney disease. Ann Intern Med 2004 Dec; 141 (12): 929-37
13. Schwartz GJ, Haycock GB, Edelmann CM, et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976 Aug; 58 (2): 259-63
14. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987 Jun; 34 (3): 571-90
15. Pierrat A, Gravier E, Saunders C, et al. Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas. Kid Int 2003 Oct; 64 (4): 1425-36
16. Abitbol CL, Strauss J, Zilleruelo G, et al. Validity of random urines to quantitate proteinuria in children with human immunodeficiency virus nephropathy. Pediatr Nephrol 1996 Oct; 10 (5): 598-601
17. Shield JP, Hunt LP, Baum JP, et al. Screening for diabetic microalbuminuria in routine clinical care: which method? Arch Dis Child 1995 Jun; 72 (6): 524-5
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31-41
19. Walton RJ, Bijvoet OL. Normogram for derivation of renal threshold phosphate concentration. Lancet 1975 Aug; 2 (7929): 309-10
20. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000 May; 320 (7244): 1240-3
21. Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI (6-20y). Eur J Clin Nutr 2002 Feb; 56 (2): 171-80
22. Nicholson JF, Pesce MA. References ranges for laboratory tests and procedures. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed. Philadelphia (PA): Saunders, 2004: 2396-427
23. Jones R, Stebbing J, Nelson M, et al. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antire-troviral therapy regimens is not observed more frequently. J Acquir Immune Defic Syndr 2004 Dec; 37 (4): 1489-95
24. Antoniou T, Raboud JM, Chirhin S, et al. Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study. HIV Medicine 2005 Jul; 6 (4): 284-90
25. Izzedine H, Hulot JS, Vittecoq D, et al. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients: data from a double-blind randomised active-controlled multicentre study. Nephrol Dial Transplant 2005 Apr; 20 (4): 743-6
26. Toto RD. Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance. Curr Opin Nephrol Hypertens 1995 Nov; 4 (6): 505-9
27. Hadj-Aissa A, Cochat P. La mesure de la fonction rénale chez l'enfant. Arch Pediatr 1994; 1: 273-80
28. Gilead Sciences Inc. Viread (tenofovir) product monograph. Foster City (CA): Gilead Sciences Inc., 2003
29. Alinei P, Guignard JP. Assessment of glomerular filtration rate in infants: comparison of three methods used in clinical practice. Helv Paediatr Acta 1987; 42 (4): 253-62
30. Rollot F, Nazal EM, Chauvelot-Moachon L, et al. Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine. Clin Infect Dis 2003 Dec; 37 (12): e174-6
31. Karras A, Lafaurie M, Furco A, et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome and nephrogenic diabetes insipidus. Clin Infect Dis 2003 Apr; 36 (8): 1070-3
32. Peyriere H, Reynes J, Rouanet J, et al. Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr 2004 Mar; 35 (3): 269-73
33. Rosenberg ME, Hostetter TH. Proteinuria. In: Seldin DW, Giebish G, editors. The kidney: physiology and pathology. 2nd edition. New York: Raven Press, 1992: 3039-61
34. Weber MH, Verwiebe R. Alpha1-microglobulin (protein HC): features of a promising indicator of proximal tubular dysfunction. Eur J Clin Chem Clin Biochem 1992 Oct; 30 (10): 683-91
35. Woolerton J, Juri DR, Dunn PJ, et al. Urine albumin creatinine ratio and clinical correlates in a diabetic population. NZ Med J 1987 Mar; 100 (819): 130-4
36. Penders J, Delanghe JR. Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta 2004 Aug; 346 (2): 107-18
37. Regeniter A, Siede WH, Scholer A, et al. Interpreting complex urinary patterns with MDI LABLINK: a statistical evaluation. Clin Chim Acta 2000 Jul; 297 (1-2): 261-73